Completed

A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer

I4D-MC-JTJH - ClinicalTrials.gov - NCT02735980

The purpose of this study is to evaluate the safety and efficacy of prexasertib when given to participants with extensive stage disease small cell lung cancer (ED-SCLC). The study will evaluate how the body processes the drug and how the drug affects the body. The study will also evaluate the association between tumor response and the participant's perceived quality of life.
How long will I be in the trial?
Your participation could last up to 1 year after the last patient enrolls in the study and if you are still receiving benefit, you may continue to receive Prexasertib through a continued access program.
Email
Completed

A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung Cancer

I4D-MC-JTJH - ClinicalTrials.gov - NCT02735980

The purpose of this study is to evaluate the safety and efficacy of prexasertib when given to participants with extensive stage disease small cell lung cancer (ED-SCLC). The study will evaluate how the body processes the drug and how the drug affects the body. The study will also evaluate the association between tumor response and the participant's perceived quality of life.
How long will I be in the trial?
Your participation could last up to 1 year after the last patient enrolls in the study and if you are still receiving benefit, you may continue to receive Prexasertib through a continued access program.
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Small Cell Lung Cancer

What the trial is testing?

interventions example

Could I receive a Placebo?

no

Enrollment Goal

116

Trial Dates

May 2016 - July 2017

Trial Phase

2

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Small Cell Lung Cancer

What the trial is testing?

interventions example

Could I receive a Placebo?

no

Enrollment Goal

116

Trial Dates

May 2016 - July 2017

Trial Phase

2

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Small Cell Lung Cancer Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?